Insights

Acquisition Impact Ology Bioservices was acquired by National Resilience, Inc. in 2021, suggesting alignment with Resilience’s broader CDMO capabilities and potential cross-sell of manufacturing, development, and quality services to Resilience’s customer base.

DoD Legacy Historically strong government contracting, including a 10-year, $400+ million DoD MCM ADM program, indicates a track record in defense-related countermeasures and regulated biopharma manufacturing that can be leveraged to win similar federal opportunities.

Biologics Platform Proprietary platform technologies for production of biologics such as proteins, monoclonal antibodies, and vaccines present opportunities for collaborations or subcontracting in late-stage development, fill/finish, or scalable GMP manufacturing.

Facilities Footprint Existing 183,000-square-foot BSL-3 single-use facility positions Ology for scale-up of complex biologics and cell therapy projects, enabling discussions around cGMP manufacturing, process development, and MCM readiness with potential enterprise clients.

Funding & Growth Revenue range $10M-$25M with modest external funding suggests upside potential through expanded contracts, joint ventures, or capacity-driven partnerships as Resilience expands its manufacturing footprint and talent in Ohio and adjacent regions.

Similar companies to Ology Bioservices, Inc.

Ology Bioservices, Inc. Tech Stack

Ology Bioservices, Inc. uses 8 technology products and services including SAP FICO, MATLAB, Snowplow, and more. Explore Ology Bioservices, Inc.'s tech stack below.

Media & News

Ology Bioservices, Inc.'s Email Address Formats

Ology Bioservices, Inc. uses at least 6 email formats:
Ology Bioservices, Inc. Email FormatsExamplePercentage
First.Last@ologybio.comJohn.Doe@ologybio.com
89%
Last@ologybio.comDoe@ologybio.com
10%
First.Middle@ologybio.comJohn.Michael@ologybio.com
1%
First.Last@resilience.comJohn.Doe@resilience.com
96%
FLast@resilience.comJDoe@resilience.com
3%
FirstLast@resilience.comJohnDoe@resilience.com
1%

Frequently Asked Questions

What is Ology Bioservices, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Ology Bioservices, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ology Bioservices, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Ology Bioservices, Inc.'s official website is resilience.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Ology Bioservices, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, Ology Bioservices, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Ology Bioservices, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Ology Bioservices, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ology Bioservices, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, Ology Bioservices, Inc. has approximately 33 employees across 2 continents, including North America and Europe. Key team members include Owner: B. F., Svp Regulatory And Quality: B. E. and Executive Director, Research & Development, Acting Site Head: M. T. Explore Ology Bioservices, Inc.'s employee directory with LeadIQ.

What industry does Ology Bioservices, Inc. belong to?

Minus sign iconPlus sign icon
Ology Bioservices, Inc. operates in the Biotechnology Research industry.

What technology does Ology Bioservices, Inc. use?

Minus sign iconPlus sign icon
Ology Bioservices, Inc.'s tech stack includes SAP FICO, MATLAB, Snowplow, Microsoft SharePoint, Microsoft Entra ID, SAP Ariba, Bitbucket and Vimeo.

What is Ology Bioservices, Inc.'s email format?

Minus sign iconPlus sign icon
Ology Bioservices, Inc.'s email format typically follows the pattern of First.Last@ologybio.com. Find more Ology Bioservices, Inc. email formats with LeadIQ.

How much funding has Ology Bioservices, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, Ology Bioservices, Inc. has raised $8.4M in funding. The last funding round occurred on Sep 17, 2018 for $8.4M.
Ology Bioservices, Inc. logo

Ology Bioservices, Inc.

Biotechnology ResearchFlorida, United States11-50 Employees

Ology Bioservices, Inc. is a biotechnology research company based in Alachua, Florida. It provides development and manufacturing services for biopharmaceutical products and medical devices, including preclinical and clinical development, formulation optimization, and cGMP manufacturing. In April 2021, Ology Bioservices was acquired by National Resilience, Inc., becoming part of Resilience. The company was founded in 1999 to pursue an integrated development and manufacturing model and maintains collaborations with industry partners and U.S. government agencies such as NIH, DoD, NCI, and BARDA. A notable milestone in its history is a 2013 Department of Defense contract to establish a Medical Countermeasures Advanced Development and Manufacturing facility, including a 183,000-square-foot BSL-3, single-use facility, which the company now occupies and operates.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $8.4M

    Ology Bioservices, Inc. has raised a total of $8.4M of funding over 1 rounds. Their latest funding round was raised on Sep 17, 2018 in the amount of $8.4M as a Grant.

  • $10M - $25M

    Ology Bioservices, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.